Transurethral Vapor Ablation in Patients with Intermediate-Risk Localized Prostate Cancer.

Dixon CM, Levin RM, Cantrill CH, Regelman M, Spilseth B, Tutrone RF Jr, White MA, Milbank AJ, Warlick CA

Open source

DOI
10.1089/end.2022.0452
Published
2023 Feb
Container
Journal of endourology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1089/end.2022.0452,
  title = {Transurethral Vapor Ablation in Patients with Intermediate-Risk Localized Prostate Cancer.},
  author = {Dixon CM and Levin RM and Cantrill CH and Regelman M and Spilseth B and Tutrone RF Jr and White MA and Milbank AJ and Warlick CA},
  year = {2023},
  journal = {Journal of endourology},
  doi = {10.1089/end.2022.0452},
  url = {https://doi.org/10.1089/end.2022.0452}
}

RIS

TY  - JOUR
TI  - Transurethral Vapor Ablation in Patients with Intermediate-Risk Localized Prostate Cancer.
AU  - Dixon CM
AU  - Levin RM
AU  - Cantrill CH
AU  - Regelman M
AU  - Spilseth B
AU  - Tutrone RF Jr
AU  - White MA
AU  - Milbank AJ
AU  - Warlick CA
PY  - 2023
JO  - Journal of endourology
DO  - 10.1089/end.2022.0452
UR  - https://doi.org/10.1089/end.2022.0452
ER  - 

APA

CM, D., RM, L., CH, C., M, R., B, S., Jr, T. R., MA, W., AJ, M., & CA, W. (2023). Transurethral Vapor Ablation in Patients with Intermediate-Risk Localized Prostate Cancer.. Journal of endourology. https://doi.org/10.1089/end.2022.0452

Source records